Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
TXG holding history
10x Genomics, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXG overviewAll 13F holders of TXGFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −204,847−100.0% | Sold out | Holders |
| Q2 2025 | 204,847 | $2.67M | <0.1% | −115,493−36.1% | Reduced | Holders |
| Q1 2025 | 320,340 | $2.55M | <0.1% | +318,352+16,013.7% | Added | Holders |
| Q4 2024 | 1,988 | $31.5K | <0.1% | −98,904−98.0% | Reduced | Holders |
| Q3 2024 | 100,892 | $2.03M | <0.1% | +100,811+124,458.0% | Added | Holders |
| Q2 2024 | 81 | $1.52K | <0.1% | −62,044−99.9% | Reduced | Holders |
| Q1 2024 | 62,125 | $1.80M | <0.1% | +19,844+46.9% | Added | Holders |
| Q4 2023 | 42,281 | $2.15M | <0.1% | +7,514+21.6% | Added | Holders |
| Q3 2023 | 34,767 | $1.34M | <0.1% | −9,322−21.1% | Reduced | Holders |
| Q2 2023 | 44,089 | $2.50M | <0.1% | −28,178−39.0% | Reduced | Holders |
| Q1 2023 | 72,267 | $3.71M | <0.1% | +31,708+78.2% | Added | Holders |
| Q4 2022 | 40,559 | $1.70M | <0.1% | +40,559 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −26,840−100.0% | Sold out | Holders |
| Q2 2022 | 26,840 | $1.16M | <0.1% | −125,694−82.4% | Reduced | Holders |
| Q1 2022 | 152,534 | $11.2M | <0.1% | −32,839−17.7% | Reduced | Holders |
| Q4 2021 | 185,373 | $19.4M | <0.1% | −7,706−4.0% | Reduced | Holders |
| Q3 2021 | 193,079 | $28.1M | <0.1% | +1,110+0.6% | Added | Holders |
| Q2 2021 | 191,969 | $37.6M | <0.1% | – | No prior filing | Holders |